Skip to main content

Bio-Rad Stock Drops 16.8 Percent Amid Broad Decline in Index

Shares in Bio-Rad dropped 16.8 percent for the five-day trading period ended Tuesday. The firm’s shares took a hit due to an underwhelming financial forecast during its fourth-quarter conference call last week (see related article, this issue), and a drop in stocks across the board. Luminex was the other member of the BCW Index to decline by double-digit figures, falling 11.1 percent for the tracking period.
 
Twenty of the 22 firms in the Index lost value for the week, with only Bruker and Stratagene gaining ground. Bruker closed the week up 6.8 percent, while Stratagene gained 3.2 percent.
 
Overall, the Index fell 5.5 percent, a steeper drop than the comparator indices. The Dow Jones Industrial Average fell 4.3 percent for the week, while the Nasdaq dropped 4.2 percent, and the Nasdaq Biotech Index declined 4.4 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price (Feb. 27, 2007)
Starting Price Jan. (Feb. 20, 2007)
% change
Affymetrix
AFFX
25.94
28.23
-8.11
Agilent
A
32.15
32.49
-1.05
Applied Biosystems
ABI
31.15
32.5
-4.15
Beckman
BEC
64.74
66.25
-2.28
Becton Dickinson
BDX
74.75
77.5
-3.55
Bio-Rad
BIO
71.76
86.24
-16.79
Bruker
BRKR
8.99
8.42
6.77
Caliper
CALP
5.99
6.2
-3.39
Cepheid
CPHD
8.27
8.75
-5.49
Illumina
ILMN
33.64
37.07
-9.25
Invitrogen
IVGN
64.35
66.39
-3.07
Luminex
LMNX
14.07
15.82
-11.06
Millipore
MIL
71.68
74.46
-3.73
Molecular Devices
MDCC
35.26
35.28
-0.06
PerkinElmer
PKI
23.69
24.54
-3.46
Qiagen
QGEN
16.48
17.48
-5.72
Sequenom
SQNM
4.1
4.52
-9.29
Sigma-Aldrich
SIAL
41.35
42.3
-2.25
Stratagene
STGN
8.47
8.21
3.17
Thermo
TMO
45.59
47.95
-4.92
Third Wave
TWTI
5.46
5.83
-6.35
Waters
WAT
54.15
58.4
-7.28
BCW Index Average
33.73
35.67
-5.45
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.